Endothelin-1 induces production of the neutrophil chemotactic factor interleukin-8 by human brain-derived endothelial cells

被引:68
作者
Hofman, FM
Chen, P
Jeyaseelan, R
Incardona, F
Fisher, M
Zidovetzki, R
机构
[1] Univ So Calif, Sch Med, Dept Pathol, Los Angeles, CA 90033 USA
[2] Univ So Calif, Dept Med, Los Angeles, CA 90033 USA
[3] Univ So Calif, Dept Neurol, Los Angeles, CA 90033 USA
[4] Univ Calif Riverside, Dept Biol, Riverside, CA 92521 USA
[5] Univ Calif Riverside, Dept Neurosci, Riverside, CA 92521 USA
关键词
D O I
10.1182/blood.V92.9.3064.421a10_3064_3072
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Increased levels of endothelin-l (Et-l), a potent vasoconstrictor, have been correlated with hypertension and neuronal damage in ischemic/reperfusion injury. The presence of polymorphonuclear cells (PMNs) in the brain has been shown to be directly responsible for this observed pathology. To address the question of whether Et-l plays a role in this process, human brain-derived endothelial cells (CNS-ECs) were cultured with Et-l, The results demonstrate that Et-l induces production of the neutrophil chemoattractant interleukin-8 (IL-8) twofold to threefold after 72 hours; mRNA was maximal after 1 hour of stimulation, Conditioned culture medium derived from Et-l-stimulated CNS-ECs induced a chemotactic response in the PMN migration assay. The inflammatory cytokines tumor necrosis factor-alpha (TNF) and IL-1 beta functioned additively with Et-1 in increasing IL-8 production. In contrast, transforming growth factor-beta (TGF-beta), but not IL-10, completely abolished the effect of Et-l on IL-8 production. However, Et-l did not modulate intercellular adhesion molecule-1 (ICAM-1) expression. These data demonstrate that Et-l may be a risk factor in ischemic/reperfusion injury by inducing increased levels of the neutrophil chemoattractant IL-8. (C) 1998 by The American Society of Hematology.
引用
收藏
页码:3064 / 3072
页数:9
相关论文
共 56 条
[1]   INCREASED PMN ADHERENCE ON ENDOTHELIAL-CELLS AFTER HYPOXIA - INVOLVEMENT OF PAF, CD18 CD11B, AND ICAM-1 [J].
ARNOULD, T ;
MICHIELS, C ;
REMACLE, J .
AMERICAN JOURNAL OF PHYSIOLOGY, 1993, 264 (05) :C1102-C1110
[2]  
BAGGIOLINI M, 1994, ADV IMMUNOL, V55, P97
[3]   NEUTROPHIL-ACTIVATING PEPTIDE-1 INTERLEUKIN-8, A NOVEL CYTOKINE THAT ACTIVATES NEUTROPHILS [J].
BAGGIOLINI, M ;
WALZ, A ;
KUNKEL, SL .
JOURNAL OF CLINICAL INVESTIGATION, 1989, 84 (04) :1045-1049
[4]   ENDOTHELIN LEVELS INCREASE IN RAT FOCAL AND GLOBAL-ISCHEMIA [J].
BARONE, FC ;
GLOBUS, MYT ;
PRICE, WJ ;
WHITE, RF ;
STORER, BL ;
FEUERSTEIN, GZ ;
BUSTO, R ;
OHLSTEIN, EH .
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 1994, 14 (02) :337-342
[5]   TGF-B2 and soluble p55 TNFR modulate VCAM-1 expression in glioma cells and brain derived endothelial cells [J].
Chen, TC ;
Hinton, DR ;
Yong, VW ;
Hofman, FM .
JOURNAL OF NEUROIMMUNOLOGY, 1997, 73 (1-2) :155-161
[6]   POSTISCHEMIC ADMINISTRATION OF AN ANTI-MAC-1 ANTIBODY REDUCES ISCHEMIC CELL-DAMAGE AFTER TRANSIENT MIDDLE CEREBRAL-ARTERY OCCLUSION IN RATS [J].
CHOPP, M ;
ZHANG, RL ;
CHEN, H ;
LI, Y ;
JIANG, N ;
RUSCHE, JR .
STROKE, 1994, 25 (04) :869-875
[7]  
CLARKE T, 1991, NEW STATESMAN SOC, V4, P22
[8]   Cerebral protection in homozygous null ICAM-1 mice after middle cerebral artery occlusion - Role of neutrophil adhesion in the pathogenesis of stroke [J].
Connolly, ES ;
Winfree, CJ ;
Springer, TA ;
Naka, Y ;
Liao, H ;
Yan, SD ;
Stern, DM ;
Solomon, RA ;
GutierrezRamos, JC ;
Pinsky, DJ .
JOURNAL OF CLINICAL INVESTIGATION, 1996, 97 (01) :209-216
[9]  
DUSIN ML, 1988, J CELL BIOL, V107, P321
[10]   HIGH PLASMA-LEVELS OF ENDOTHELIN-1 AND ATRIAL-NATRIURETIC-PEPTIDE IN PATIENTS WITH ACUTE ISCHEMIC STROKE [J].
ESTRADA, V ;
TELLEZ, MJ ;
MOYA, J ;
FERNANDEZDURANGO, R ;
EGIDO, J ;
CRUZ, AF .
AMERICAN JOURNAL OF HYPERTENSION, 1994, 7 (12) :1085-1089